AC Immune (ACIU) Revenue (2015 - 2026)

AC Immune (ACIU) reported Revenue of $1.4 million for Q1 2026, up 29.77% year-over-year from $1.1 million in Q1 2025, and up 237.9% quarter-over-quarter from $422895.4 in Q4 2025.

AC Immune (ACIU) Revenue (2015 - 2026) Analysis & Trends

AC Immune (ACIU) has 10 years of Revenue data on file, last reported at $1.4 million in Q1 2026.

  • Revenue for Q1 2026 came in at $1.4 million, up 29.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (down 85.87% YoY), and the FY2025 annual result was $4.3 million, down 86.18% from the prior year.
  • Revenue climbed to $1.4 million in Q1 2026 per ACIU's latest filing, from $422895.4 in the prior quarter.
  • Over five years, Revenue peaked at $29.4 million in Q3 2024 and troughed at $422895.4 in Q4 2025.
  • A 4-year average of $4.6 million and a median of $1.3 million in 2024 frame the typical range for Revenue.
  • On a YoY basis, Revenue climbed as much as 107.65% in 2025 and fell as far as 96.01% in 2025.
  • A 4-year view of Revenue shows it stood at $4.0 million in 2022, then tumbled by 67.86% to $1.3 million in 2024, then tumbled by 67.42% to $422895.4 in 2025, then jumped by 237.9% to $1.4 million in 2026.
  • Business Quant data shows ACIU's Revenue at $1.4 million in Q1 2026, $422895.4 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 AC Immune 1.49 Bn -94.03 Bn - 1.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.43 Mn
Dec 31, 2025 422,895.39
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 29.41 Mn
Jun 30, 2024 759,680.13
Sep 30, 2022 4.04 Mn
Dec 31, 2020 1.04 Mn
Sep 30, 2020 1.22 Mn
Jun 30, 2020 1.12 Mn
Mar 31, 2020 12.70 Mn
Dec 31, 2019 868,929.92
Sep 30, 2019 2.23 Mn
Jun 30, 2019 1.51 Mn
Mar 31, 2019 75.35 Mn
Dec 31, 2018 1.13 Mn
Sep 30, 2018 2.34 Mn
Jun 30, 2018 2.06 Mn